Detail akcie OWC Pharm Research online

Business Summary: OWC Pharmaceutical Research Corp. is a medical cannabis research and development company. The Company is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The Company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. As of September 30, 2016, the Company was engaged in two business activities: work with GUMI to commercialize and market the Company's Electromagnetic Percussion Device (the Device), and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD) migraines and a delivery system.
Financial Summary: BRIEF: For the nine months ended 30 September 2019, OWC Pharmaceutical Research Corp revenues was not reported. Net income applicable to common stockholders totaled $3.8M vs. loss of $6.6M. Net income reflects Revaluation of embedded derivative relat decrease of 98% to $49K (expense), Other Non Operating I/E decrease from $823K (expense) to $0K, General and administrative decrease of 33% to $1.4M (expense).